
1. Technology overview
injewelme is a Singapore-registered AI company (injewelme Pte. Ltd., with a South Korean service provider entity) that builds digital health products from personal data. Its funding announcement in April 2026 was led by a Temasek Trust vehicle, and its products target healthcare providers, insurers and workplaces.
DeepHealthVision (DHV) estimates vital signs from a face scan using any camera and an internet connection. AI processes the remote photoplethysmography signal and returns more than 20 indicators, including heart rate, blood pressure and blood glucose, in about 30 seconds. DeepHealthNet adds time-series analytics for trend alerts. Pilots were run with SingHealth Polyclinics.
2. Highlighted features & specifications
- Face-scan vitals: Estimates more than 20 indicators such as heart rate, blood pressure and blood glucose from a camera feed.
- Real-time results: Output appears within about 30 seconds of a scan.
- Trend prediction: DeepHealthNet builds time-series records and flags risks before symptoms appear.
- Flexible delivery: SaaS subscription, a deployment package with iPad and stand, or enterprise SDK and API integration.
- Multi-platform apps: Web, mobile and Windows apps plus SDKs for Windows, iOS and Android, with an admin portal.
3. Potential application
Vietnamese insurers can add a camera-based health check to policyholder apps. Clinics and hospital outpatient halls can run quick pre-screening at registration. Factories and logistics sites can screen workers for heat stress before shifts, a use the company plans to add.
4. Benefits
No dedicated medical device is needed, since any camera-equipped device can run a scan. A scan takes about 30 seconds, which suits screening at scale. The company reports 95 percent detection accuracy in real-world pilots. Enterprises can integrate through SDK and API or white-label the product.
5. Market trends & opportunities
Demand is growing for contactless, low-cost screening in primary care, eldercare, insurance and workplace safety. Vietnam and Southeast Asia face ageing populations and rising chronic disease, and employers and insurers look for preventive tools that avoid extra hardware.
6. Other information
Singapore Pte. Ltd. (UEN 202518649M) with a South Korean service provider entity. First institutional round of US$1.2 million in April 2026 led by C3H (Temasek Trust) with the Richardson Family office. Partners listed: SingHealth Polyclinic, Surbana Jurong.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE








































